Real-estate lessor in FR. Official registry identity, source coverage and the current valuation evidence status on one public company profile.
PROMED BIOMEDICAL has public figures, but the legal status or filing freshness makes an automated going-concern multiple misleading. Verify current continuity and owner context before showing a range.
Create a free account to add verified turnover, normalised EBITDA, debt and one-offs for PROMED BIOMEDICAL in a private workspace.
We keep this public page conservative, so weak filings never become a false price.The page can still show filed facts, but the automatic public range is blocked when those facts would make the multiple misleading.
PROMED BIOMEDICAL is a real-estate lessor based in France. The company was founded in 1984, incorporated as a 5599.
PROMED BIOMEDICAL is listed in French National Business Register (RNE/INPI) under registry number 331874412. This profile consolidates official annual accounts into one indexable company dossier.
Companies in this NACE 68.20 band file annual accounts with INPI.
The most recent annual filing covers 2018 (period end 2018-12-31).
If you are researching PROMED BIOMEDICAL, this page combines its official registry profile and company-size evidence with a broad indicative range.
PROMED BIOMEDICAL's indicative range combines official company-size information with sector multiples. It publishes no midpoint, asking price, offer, or recommendation and only becomes company-specific after refinement with owner or advisor data.
Express interest and ask Upswitch to discreetly sound out the owner. We review every request before making contact.
This is an estimate, not an asking price. It is based on dated public sources and is not an owner forecast, offer, investment advice, or confirmation that the company is for sale.
Request verified control to add current figures, improve the profile and manage what happens next. We verify ownership before granting access.
Public regulator-filed figures across 7 years.
Fiscal year | Revenue | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202331 Dec 2023 | - | - | €1,043,896 | €1,021,290 | - |
| 202231 Dec 2022 | - | - | €1,080,122 | €1,052,251 | - |
| 202031 Dec 2020 | - | - | €1,172,572 | €1,116,348 | - |
| 201931 Dec 2019 | - | - | €1,223,960 | €1,192,611 | - |
| 201831 Dec 2018 | - | - | €1,270,929 | €1,237,845 | - |
| 201731 Dec 2017 | - | - | €2,159,777 | €1,170,508 | - |
| 201631 Dec 2016 | - | - | €2,159,914 | €1,159,664 | - |
PROMED BIOMEDICAL was founded in 1984 and is registered with French National Business Register (RNE/INPI), incorporated as a 5599.
PROMED BIOMEDICAL is registered under NACE 68.20: NACE 68.20. That places the business within the French cluster for this activity.
The most recently filed annual accounts cover fiscal year 2018 (period end 2018-12-31), publicly available via French National Business Register (RNE/INPI).
This page shows official or licensed public company facts and valuation-readiness context for PROMED BIOMEDICAL; it does not show an automated public valuation range. The available facts may be incomplete or inaccurate and must not be relied upon for any transaction; a precise valuation needs owner- or advisor-supplied data.
Company identity and public facts are reused from the official or licensed source named on this page, with its filing or update date. Upswitch estimates remain distinct from source facts and do not imply endorsement by the registry. Natural-person enterprises are excluded from public valuation pages, and public registry personal data is not used for direct marketing.
Connected to this company and want something corrected? Request a correction or removal · Privacy policy · Terms & conditions · Data sources & evidence
